// App-Quantinova.ai

: Survival effects of pulmonary vasodilators in group 3 pulmonary hypertension

Researchers

Presenter

  • Timothy Dawes

Principal Investigators

  • Konstantinos Dimopoulos

  • Colm Mccabe

  • Simon Bax

  • Aleksander Kempny

  • Philip Molyneaux

  • Peter George

  • Vasilis Kouranos

  • Felix Chua

  • Elisabetta Renzoni

  • Maria Kokosi

  • Athol U Wells

  • S John Wort

  • Laura C Price

Medical Centers

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

  • National Pulmonary Hypertension Service, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved